Crossref
COMPARATIVE POSTMARKETING ANALYSIS OF ANAPHYLAXIS WITH RESPIRATORY BIOLOGICS USING THE FDA ADVERSE EVENT REPORTING SYSTEM
Annals of Allergy, Asthma & Immunology · 2026-11 · 137 (5) · S3
DOI: 10.1016/j.anai.2026.09.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Allergy, Asthma & Immunology, 2026-11. Verfasst von J. Priessnitz und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Priessnitz, J., Han, J., & Lam, K. (2026). COMPARATIVE POSTMARKETING ANALYSIS OF ANAPHYLAXIS WITH RESPIRATORY BIOLOGICS USING THE FDA ADVERSE EVENT REPORTING SYSTEM. Annals of Allergy, Asthma & Immunology, 137(5), S3. https://doi.org/10.1016/j.anai.2026.09.005
Vancouver
Priessnitz J, Han J, Lam K. COMPARATIVE POSTMARKETING ANALYSIS OF ANAPHYLAXIS WITH RESPIRATORY BIOLOGICS USING THE FDA ADVERSE EVENT REPORTING SYSTEM. Annals of Allergy, Asthma & Immunology. 2026;137(5):S3. doi:10.1016/j.anai.2026.09.005
BibTeX
@article{Priessnitz2026,
author = {Priessnitz, J. and Han, J. and Lam, K.},
title = {COMPARATIVE POSTMARKETING ANALYSIS OF ANAPHYLAXIS WITH RESPIRATORY BIOLOGICS USING THE FDA ADVERSE EVENT REPORTING SYSTEM},
journal = {Annals of Allergy, Asthma & Immunology},
year = {2026},
volume = {137},
number = {5},
pages = {S3},
doi = {10.1016/j.anai.2026.09.005}
}
EUVIMED